12,600€
-0,40%
Echtzeit-Aktienkurs KIRIN HOLDINGS CO. LTD.
Bid:
Ask:
Echtzeit-Chart der KIRIN HOLDINGS CO. LTD. Aktie
Fundamentaldaten der KIRIN HOLDINGS CO. LTD. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2024 [USD] | 15,44 Mrd. | 677,82 Mio. | 384,26 Mio. | 0,47 | 2,70% | 26,58 | 0,66 |
| 2023 [USD] | 15,18 Mrd. | 1,17 Mrd. | 801,47 Mio. | 0,99 | 3,13% | 12,73 | 0,67 |
| 2022 [USD] | 15,13 Mrd. | 1,28 Mrd. | 843,98 Mio. | 1,03 | 3,08% | 12,27 | 0,67 |
| 2021 [USD] | 16,58 Mrd. | 592,75 Mio. | 544,17 Mio. | 0,65 | 3,38% | 19,30 | 0,63 |
| 2020 [USD] | 17,32 Mrd. | 934,71 Mio. | 673,75 Mio. | 0,80 | 3,74% | 15,73 | 0,61 |
| 2019 [USD] | 17,81 Mrd. | 762,32 Mio. | 547,12 Mio. | 0,62 | 3,97% | 20,19 | 0,61 |
| 2018 [USD] | 17,48 Mrd. | 1,98 Mrd. | 1,49 Mrd. | 1,66 | 2,70% | 7,58 | 0,63 |
| 2017 [USD] | 16,62 Mrd. | 1,85 Mrd. | 2,16 Mrd. | 2,37 | 2,53% | 5,33 | 0,69 |
| 2016 [USD] | 19,10 Mrd. | 1,55 Mrd. | 1,09 Mrd. | 1,19 | 2,16% | 10,57 | 0,60 |
| 2015 [USD] | 18,15 Mrd. | 143,91 Mio. | -390,94 Mio. | -0,43 | 1,92% | - | 0,63 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der KIRIN HOLDINGS CO. LTD. Aktie
Kirin Holdings Co., Ltd. engages in the manufacture and sale of beverages and pharmaceutical products. It operates through the following segments: Japan Beer and Spirits, Japan Non-Alcoholic Beverages, Oceania Integrated Beverages, Pharmaceuticals, and Other. The Japan Beer and Spirits segment manufactures and sells beer, sparkling wine, Western liquor, and other alcoholic beverages through its subsidiary. The Japan Non-Alcoholic Beverages segment handles the manufacture and sale of soft drinks in Japan through its subsidiary. The Oceania Integrated Beverages segment provides beer, Western liquor, dairy products, and fruit juice drinks in the Oceania region through its subsidiary. The Pharmaceuticals segment deals with prescription drugs through its subsidiary. The Other segment includes domestic wine, Myanmar liquor, North American beverage, and biochemical businesses. The company was founded on February 23, 1907 and is headquartered in Tokyo, Japan.